Synlett 2010(19): 2918-2922  
DOI: 10.1055/s-0030-1259014
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

New Methodology for the Synthesis of 3-Substituted Coumarins via Palladium-Catalyzed Site-Selective Cross-Coupling Reactions

Sérgio Martinsa, Paula S. Brancob, María C. de la Torrec, Miguel A. Sierrad, António Pereira*a
a Centro de Química, Departamento de Química,, Universidade de Évora, 7000-671 Évora, Portugal
Fax: +351(266)745303; e-Mail: [email protected];
b REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, FCT, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal
c Instituto de Química Orgánica General, Consejo Superior de Investigaciones Científicas (CSIC), 28006 Madrid, Spain
d Departamento de Química Orgánica, Facultad de Química, Universidad Complutense, 28040 Madrid, Spain
Further Information

Publication History

Received 21 July 2010
Publication Date:
03 November 2010 (online)

Abstract

A particularly useful, easy, and concise synthesis of diversified 3-aryl coumarin was achieved using Heck coupling reactions between coumarin and aryliodides. The introduction of the aryl moiety occurred regioselective at the 3-position of the heteroaromatic ring.

    References and Notes

  • 1a Hoult JRS. Paya M. Gen. Pharmacol.  1996,  27:  713 
  • 1b Kostova I. Curr. Med. Chem.  2005,  5:  29 
  • 1c Dayam R. Gundla R. Al-Mawsawi LQ. Neamati N. Med. Res. Rev.  2008,  28:  118 
  • 1d Thuong PT. Hung TM. Ngoc TM. Ha DT. Min BS. Kwack SJ. Kang TS. Choi JS. Bae K. Phytother. Res.  2010,  24:  101 
  • 1e Coumarins: Biology, Applications and Mode of Action   Wiley; Chichester: 1997. 
  • 2a Jones G. Jackson WR. Choi C. Bergmark WR.
    J. Phys. Chem.  1985,  89:  294 
  • 2b Koefod RS. Mann KR. Inorg. Chem.  1989,  28:  2285 
  • 2c Jagtap AR. Satam VS. Rajule RN. Kanetkar VR. Dyes Pigm.  2009,  82:  84 
  • 3a Lee MT. Yen CK. Yang WP. Chen HH. Liao CH. Tsai CH. Chen CH. Org. Lett.  2004,  6:  1241 
  • 3b Swanson SA. Wallraff GM. Chen JP. Zhang WJ. Bozano LD. Carter KR. Salem JR. Villa R. Scott JC. Chem. Mat.  2003,  15:  2305 
  • 3c Chang CH. Cheng HC. Lu YJ. Tien KC. Lin HW. Lin CL. Yang CJ. Wu CC. Org. Electron.  2010,  11:  247 
  • 3d Yu TZ. Zhang P. Zhao YL. Zhang H. Meng J. Fan DW. Org. Lett.  2009,  10:  653 
  • 4a Dorlars A. Schellhammer CW. Schroeder J. Angew. Chem., Int. Ed. Engl.  1975,  14:  665 
  • 4b Keskin SS. Aslan N. Bayrakceken N. Spectrochim. Acta, Part A  2009,  72:  254 
  • 5a Moylan CR. J. Phys. Chem.  1994,  98:  13513 
  • 5b Mashraqui SH. Mistry H. Sundaram S. J. Heterocycl. Chem.  2006,  43:  917 
  • 5c Painelli A. Terenziani F. Synth. Met.  2001,  124:  171 
  • 6 Wilze KA. Johnson AK. Production, In Handbook of Detergents, Chemistry, Production, and Application of Fluorescent Whitening Agents   Part F:  CRC Press, Taylor and Francis; Boca Raton / FL: 2007. 
  • 7a Kim JH. Kim HJ. Kim SH. Lee JH. Do JH. Kim HJ. Lee JH. Kim JS. Tetrahedron Lett.  2009,  50:  5958 
  • 7b Jung HS. Kwon PS. Lee JW. Kim JI. Hong CS. Kim JW. Yan SH. Lee JY. Lee JH. Joo T. Kim JS. J. Am. Chem. Soc.  2009,  131:  2008 
  • 7c Sheng RL. Wang PF. Gao YH. Wu Y. Liu WM. Ma JJ. Li HP. Wu SK. Org. Lett.  2008,  10:  5015 
  • 7d Kim HJ. Park JE. Choi MG. Ahn S. Chang SK. Dyes Pigm.  2010,  84:  54 
  • 7e Lin WY. Yuan L. Cao XW. Tan W. Feng YM. Eur. J. Org. Chem.  2008,  4981 
  • 8a Goddard J.-P. Reymond J.-L. Trends Biotechnol.  2004,  22:  363 
  • 8b Heiner S. Detert H. Kuhn A. Kunz H. Bioorg. Med. Chem.  2006,  14:  6149 
  • 9a Mayer G. Heckel A. Angew. Chem. Int. Ed.  2006,  45:  4900 
  • 9b Geiβler D. Antonenko YN. Schmidt R. Keller S. Krylova OO. Wiesner B. Bendig J. Pohl P. Hagen V. Angew. Chem. Int. Ed.  2005,  44:  1195 
  • 10a Mizukami S. Okada S. Kimura S. Kikuchi K. Inorg. Chem.  2009,  48:  7630 
  • 10b Wagner BD. Molecules  2009,  14:  210 
  • 10c Hara K. Kurashige M. Dan-oh Y. Kasada C. Shinpo A. Suga S. Sayama K. Arakawa H. New J. Chem.  2003,  27:  783 
  • 10d Camur M. Bulut M. Kandaz M. Guney O. Supramol. Chem.  2009,  21:  624 
  • 11a Matos MJ. Vina D. Picciau C. Orallo F. Santana L. Uriarte E. Bioorg. Med. Chem. Lett.  2009,  19:  5053 
  • 11b Matos MJ. Vina D. Quezada E. Picciau C. Delogu G. Orallo F. Santana L. Uriarte E. Bioorg. Med. Chem. Lett.  2009,  19:  3268 
  • 11c Kabeya LM. da Silva C. Kanashiro A. Campos JM. Azzolini A. Polizello ACM. Pupo MT. Lucisano-Valim YM. Eur. J. Med. Chem.  2008,  43:  996 
  • 12 Kabeya LM. de Marchi AA. Kanashiro A. Lopes NP. da Silva C. Pupo MT. Lucisano-Valima YM. Bioorg. Med. Chem.  2007,  15:  1516 
  • 13a Pechmann VHDC. Ber. Dtsch. Chem. Ges.  1884,  17:  929 
  • 13b Perkin WH. J. Chem. Soc.  1875,  28:  10 
  • 13c Johnson JR. Org. React.  1942,  1:  210 
  • 13d Cairns N. Harwood LM. Astles DP. J. Chem. Soc., Perkin Trans. 1  1994,  3101 
  • 13e Jones G. Org. React.  1967,  15:  204 
  • 13f Brufola G. Fringuelli F. Piermatti O. Pizzo F. Heterocycles  1996,  43:  1257 
  • 13g Shirner RL. Org. React.  1942,  1:  1 
  • 13h Narasimhan NS. Mali RS. Barve MV. Synthesis  1979,  906 
  • 13i Yavari I. Hekmat-Shoar R. Zonouzi A. Tetrahedron Lett.  1998,  39:  2391 
  • 14 Oyamada J. Kitamura T. Tetrahedron  2006,  62:  6918 
  • 15 Cacchi S. Pure Appl. Chem.  1996,  68:  45 
  • 16a Kadnikov DV. Larock RC. Org. Lett.  2000,  2:  3643 
  • 16b Aoki S. Amamoto C. Oyamada J. Kitamura T. Tetrahedron  2005,  61:  9291 
  • 16c Kadnikov DV. Larock RC. J. Org. Chem.  2003,  68:  9423 
  • 17a Das AR. Medda A. Singha R. Tetrahedron Lett.  2010,  51:  1099 
  • 17b Reddy CR. Srikanth B. Rao NN. Shin DS. Tetrahedron  2008,  64:  11666 
  • 17c Zhang L. Meng T. Fan R. Wu J. J. Org. Chem.  2007,  72:  7279 
  • 18 Vernin G. Coen S. Metzger J. Parkanyi C. J. Heterocycl. Chem.  1979,  16:  97 
  • 19 Buuhoi NP. Hoan N. Khenissi MR. J. Chem. Soc.  1951,  2307 
  • 21 Chandra V. Srivasta VB. J. Indian Chem. Soc.  1969,  46:  1102 
  • 22 Mashraqui SH. Vashi D. Mistry HD. Synth. Commun.  2004,  34:  3129 
  • 23 Cabri W. Candiani I. Accounts Chem. Res.  1995,  28: 
  • 24 Pastre JC. Correia CRD. Adv. Synth. Catal.  2009,  351:  1217 
  • 25 Stoermer R. Friderici E. Ber. Dtsch. Chem. Ges.  1908,  41:  324 
  • 26 Felfoldi K. Sutyinszky M. Nagy N. Palinko I. Synth. Commun.  2000,  30:  1543 
  • 27 Yu WF. Tsoi YT. Zhou ZY. Chan ASC. Org. Lett.  2009,  11:  469 
  • 28 Stoermer R. Ber. Dtsch. Chem. Ges.  1911,  44:  637 
20

General Procedure for the Pd-Catalyzed Coupling of Coumarin with Aryliodides
Under a nitrogen atmosphere, a mixture of coumarin (146 mg, 1.0 mmol, 3.0 equiv), aryl iodide (1.0 equiv), Pd(PPh3)4 (10 mol%), and MeCO2Ag (1.1 equiv) in DMF (2.0 mL) was stirred at 80 ˚C for a period of 72 h. The reaction mixture was diluted with EtOAc and washed with H2O. The organic layer was dried (Na2SO4), filtered, and concentrated under vacuum. The residue was purified by flash column chroma-tography on silica gel (230-400 mesh; hexane-CH2Cl2 gradient). 3-(4-Bromophenyl)coumarin (3b) ¹H NMR (400 MHz, CDCl3): δ = 7.31 (1 H, dd, J = 7.5, 7.4 Hz, H-6), 7.37 (1 H, d, J = 8.5 Hz, H-8), 7.53-7.61 (6 H, m, H-5, H-7, H-2′, H-3′, H-5′, H-6′), 7.82 (1 H, s, H-4). ¹³C NMR (100 MHz, CDCl3): δ = 116.6 (C-8), 119.5 (C-4a), 123.2 (C-4′), 124.6 (C-6), 127.2 (C-3), 128.0 (C-5), 130.1 (C-2′, C-6′), 131.7 (C-7, C-3′, C-5′), 133.6 (C-1′), 139.9
(C-4), 153.6 (C-8a), 160.3 (C-2). MS (EI+): m/z (%) = 299 [M79Br - H]+(100), 273 [MBr - CO]+(71). HRMS (EI+):
m/z calcd for C15H9BrO2 [M]+: 299.9786; found: 299.9790.
3-(4-Ethylphenyl)coumarin (3c) ¹H NMR (400 MHz, CDCl3): δ = 1.27 (3 H, t, J = 7.6 Hz, CH2CH3), 2.70 (2 H, q, J = 7.6 Hz, CH2CH3), 7.29 (2 H, d, J = 8.2 Hz, H-3′, H-5′), 7.30 (1 H, dd, J = 7.7, 7.7 Hz, H-6), 7.37 (1 H,d, J = 8.0 Hz, H-8), 7.52 (1 H, dd, J = 8.0, 7.7 Hz, H-7), 7.54 (1 H, d, J = 7.7 Hz, H-5), 7.63 (2 H, d, J = 8.2 Hz, H-2′, H-6′), 7.80 (1 H, s, H-4). ¹³C NMR (100 MHz, CDCl3): δ = 15.5 (CH2CH3), 28.7 (CH2CH3), 116.4 (C-8), 119.8 (C-4a), 124.4 (C-6), 127.8 (C-5), 128.0 (C-3′, C-5′), 128.5 (C-3, C-2′, C-6′), 131.2 (C-7), 132.0 (C-1′), 139.2 (C-4), 145.2 (C-4′), 153.4 (C-8a), 160.7 (C-2). MS (EI+): m/z (%) = 250 [M]+ (99.5), 235 [M - CH3]+(100), 222 [M - CO]+ (17.87), 207 [M - CO2 + H]+(77). HRMS (EI+): m/z calcd for C17H14O2 [M]+: 250.0994; found: 250.0993.
3-(4-Iodophenyl)coumarin (3d) ¹H NMR (400 MHz, CDCl3): δ = 7.31 (1 H, dd, J = 7.1, 7.1 Hz, H-6), 7.37 (1 H, d, J = 8.2 Hz, H-8), 7.46 (2 H, d, J = 7.0 Hz, H-2′, H-6′), 7.53-7.56 (2 H, m, H-5, H-7), 7.79 (2 H, d, J = 7.0 Hz, H-3′, H-5′), 7.82 (1 H, s, H-4). ¹³C NMR (100 MHz, CDCl3): δ = 95.0 (C-4′), 116.5 (C-8), 119.5 (C-4a), 124.6 (C-6), 127.3 (C-3), 128.0 (C-5), 130.2 (C-2′, C-6′), 131.7 (C-7), 134.2 (C-1′), 137.6 (C-3′, C-5′), 139.9 (C-4), 153.6 (C-8a), 160.2 (C-2). MS (EI+): m/z (%) = 347 [M]+(61), 57 [C2HO2](100). HRMS (EI+): m/z calcd for C15H9IO2 [M]+: 347.9647; found: 347.9645.
4-(Coumarin-3-yl)benzaldehyde (3e) ¹H NMR [400 MHz, CO(CD3)2]: δ = 7.40 (2 H, m, H-6, H-8), 7.67 (1 H, dd, J = 7.2, 6.8 Hz, H-7), 7.80 (1 H, d, J = 6.8 Hz, H-5), 8.02 (4 H, br s, H-2′, H-3′, H-5′, H-6′), 8.31 (1 H, s, H-4), 10.10 (1 H, s, CHO). ¹³C NMR [100 MHz, CO(CD3)2]: δ = 116.9 (C-8), 120.5 (C-4a), 125.5 (C-6), 127.5 (C-3), 129.7 (C-5), 130.1 (C-2′, C-6′), 130.2 (C-3′,
C-5′), 133.0 (C-7), 137.4 (C-4′), 141.8 (C-1′), 142.4 (C-4), 154.8 (C-8a), 160.2 (C-2), 192.5 (CHO). MS (EI+): m/z (%) 249 [M - H]+ (73.71), 221 [M - CO]+ (14.6), 220 [M - CHO]+ (17.9), 57 [C2HO2](100). HRMS (EI+): m/z calcd for C16H10O3 [M]+ 250.0630; found: 250.0632.
3-(4-Nitrophenyl)coumarin (3f) ¹H NMR (400 MHz, CDCl3): δ = 7.36 (1 H, dd, J = 7.6, 6.8 Hz, H-6), 7.41 (1 H, d, J = 8.2 Hz, H-8), 7.60 (1 H, d, J = 7.6 Hz, H-5), 7.61 (1 H, dd, J = 8.2, 6.8 Hz, H-7), 7.92 (2 H, d, J = 8.8 Hz, H-2′, H-6′), 7.95 (1 H, s, H-4), 8.33 (2 H, d, J = 8.8 Hz, H-3′, H-5′). ¹³C NMR (100 MHz, CDCl3): δ = 116.7 (C-8), 119.1 (C-4a), 123.7 (C-3′, C-5′), 124.9 (C-6), 126.1 (C-3), 128.4 (C-5), 129.5 (C-2′, C-6′), 132.6 (C-7), 141.0 (C-1′), 141.6 (C-4), 147.8 (C-4′), 153.9 (C-8a), 159.8 (C-2). MS (EI+): m/z (%) = 267 [M]+(100), 239 [M - CO]+ (17.4). HRMS (EI+): m/z calcd for C15H9NO4 [M]+: 267.0532; found: 267.0533.
3-(4-Methoxyphenyl)coumarin (3g) ¹H NMR [400 MHz, CO(CD3)2]: δ = 3.84 (3 H, s, OCH3), 7.01 (2 H, d, J = 8.0 Hz, H-3′, H-5′), 7.36 (2 H, m, H-6, H-8), 7.59 (1 H, dd, J = 7.8, 7.5 Hz, H-7), 7.75 (3 H, m, H-5, H-2′, H-6′), 8.07 (1 H, s, H-4). ¹³C NMR [100 MHz, CO(CD3)2]: δ = 55.6 (OCH3), 114.5 (C-3′, C-5′), 116.7 (C-8), 120.9 (C-4a), 126.0 (C-6, C-3), 129.1 (C-5, C-1′), 130.7 (C-2′, C-6′), 131.9 (C-7), 139.4 (C-4), 154.0 (C-8a), 160.5 (C-4′), 161.1 (C-2). MS (EI+): m/z (%) = 252 [M]+(100), 209 [M - CO + CH3]+ (53.2). HRMS (EI+): m/z calcd for C16H12O3 [M]+: 252.0786; found: 252.0785.
( E )-Methyl 3-[4-(coumarin-3-yl)phenyl]acrylate (9) ¹H NMR (400 MHz, CDCl3): δ = 3.82 (3 H, s, OCH3), 6.49 (1 H, d, J = 16.0 Hz, CHCHCO), 7.32 (1 H, dd, J = 7.6, 7.6 Hz, H-6), 7.38 (1 H, d, J = 8.3 Hz, H-8), 7.55 (1 H, dd, J = 8.3, 7.6 Hz, H-7), 7.56 (1 H, d, J = 7.6 Hz, H-5), 7.60 (2 H, d, J = 8.1 Hz, H-3′, H-5′), 7.72 (1 H, d, J = 16.0 Hz, CHCHCO), 7.76 (2 H, d, J = 8.4 Hz, H-2′, H-6′), 7.87 (1 H, s, H-4). ¹³C NMR (100 MHz, CDCl3): δ = 51.8 (OCH3), 116.5 (C-8), 118.6 (CHCHCO), 119.5 (C-4a), 124.6 (C-6), 127.5 (C-3), 128.0 (C-5), 128.1 (C-3′, C-5′), 129.0 (C-2′, C-6′), 131.8 (C-7), 134.8 (C-4′), 136.5 (C-1′), 140.1 (C-4), 144.0 (CHCHCO), 153.6 (C-8a), 160.3 (C-2), 167.3 (CHCHCO). MS (EI+): m/z (%) = 306 [M]+ (63.15). HRMS (EI+): m/z calcd for C19H14O4 [M]+: 306.0892; found: 306.0896.